Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 2/2011

01-04-2011 | Introduction to Review Articles

Basic science and clinical frontiers of sarcoma treatment

Author: Hiroyuki Tsuchiya

Published in: International Journal of Clinical Oncology | Issue 2/2011

Login to get access

Excerpt

In 2008, 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred worldwide. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths [1]. …
Literature
1.
2.
Tsuchiya H, Tomita K, Mori Y et al (1999) Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 358:27–35PubMedCrossRef
3.
Kanazawa Y, Tsuchiya H, Nonomura A et al (2003) Intentional marginal excision of osteosarcoma of the proximal fibula to preserve limb function. J Orthop Sci 8:757–761PubMedCrossRef
4.
Enneking WF, Spanier SS, Goodman MA (1980) A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106–120PubMed
Metadata
Title
Basic science and clinical frontiers of sarcoma treatment
Author
Hiroyuki Tsuchiya
Publication date
01-04-2011
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 2/2011
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-011-0219-1

Other articles of this Issue 2/2011

International Journal of Clinical Oncology 2/2011 Go to the issue

Original Article

Inhibitory effects of dietary glucosylceramides on squamous cell carcinoma of the head and neck in NOD/SCID mice

Editorial Announcement

Announcing our new journal: International Cancer Conference Journal (ICCJ)

Review Article

Proteomic analysis of soft tissue sarcoma

Case Report

Spindle cell carcinoma of the nasal cavity

Original Article

Usage of granulocyte colony-stimulating factor every 2 days is clinically useful and cost-effective for febrile neutropenia during early courses of chemotherapy

Original Article

Hepatic resection with or without adjuvant iodine-131-lipiodol for hepatocellular carcinoma: a comparative analysis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits